survival

Open Access
Cytoreductive Surgery and HIPEC for Malignant Peritoneal Mesothelioma: Outcomes and Survival From an Australian Centre
RAPHAEL SHAMAVONIAN, ERNEST CHENG, JOSH B. KARPES, SHOMA BARAT, NIMA AHMADI and DAVID L. MORRIS

Anticancer Research June 2022, 42 (6) 2939-2944; DOI: https://doi.org/10.21873/anticanres.15776
You have access
Bevacizumab-based Salvage Chemotherapy Improves Survival Outcomes for Patients With Brain Metastasis from Ovarian Cancer
SHINICHI TATE, KYOKO NISHIKIMI, AYUMU MATSUOKA, SATOYO OTSUKA and MAKIO SHOZU

Anticancer Research May 2022, 42 (5) 2637-2644; DOI: https://doi.org/10.21873/anticanres.15741
You have access
Prognostic Impact of Immune-related Adverse Events in Gastric Cancer Patients Treated With Nivolumab
HIDEAKI SUEMATSU, KAZUKI KANO, TAKANOBU YAMADA, ITARU HASHIMOTO, HAYATO WATANABE, KOSUKE TAKAHASHI, MAMORU WATANABE, KEI HAYASHI, YOSHIHIRO KANETA, MITSUHIRO FURUTA, YASUHIRO INOKUCHI, NOZOMU MACHIDA, TORU AOYAMA, HIROSHI TAMAGAWA, NORIO YUKAWA, YASUSHI RINO, MUNETAKA MASUDA, TAKASHI OGATA and TAKASHI OSHIMA

Anticancer Research March 2022, 42 (3) 1535-1540; DOI: https://doi.org/10.21873/anticanres.15626
You have access
Death Receptor 6 as a Prognostic Marker in Low-grade Glioma
SARAH K. STEGMANN, SASKIA KUHL, NAM GYU IM, DANG THUY DIEM-DINH, LUKAS GOERTZ, ROLAND GOLDBRUNNER and MARCO TIMMER

Anticancer Research March 2022, 42 (3) 1237-1245; DOI: https://doi.org/10.21873/anticanres.15591
You have access
Prognostic Significance of 3-Month Prostate-specific Antigen Level Following Androgen-deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer
YUJIRO NAGATA, TAKUO MATSUKAWA, IKKO TOMISAKI and NAOHIRO FUJIMOTO

Anticancer Research February 2022, 42 (2) 1107-1114; DOI: https://doi.org/10.21873/anticanres.15573
You have access
Sacral Chordoma: A Population-based Analysis of Epidemiology and Survival Outcomes
MATTEO SCAMPA, ENRICO TESSITORE, DENNIS E. DOMINGUEZ, DIDIER HANNOUCHE, NICOLAS C. BUCHS, DANIEL F. KALBERMATTEN and CARLO M. ORANGES

Anticancer Research February 2022, 42 (2) 929-937; DOI: https://doi.org/10.21873/anticanres.15552
You have access
Intensified Total Neoadjuvant Therapy Versus Intensified Concurrent Chemoradiotherapy in Locally Advanced Rectal Cancer: A Propensity Score Matching Analysis
FRANCESCA DE FELICE, DANIELA MUSIO, FRANCO IAFRATE, SALVATORE CAPONNETTO, VINCENZO PICONE, GIANCARLO D’AMBROSIO, FABIO MASSIMO MAGLIOCCA, FRANCESCA TOZZI, GIORGIO DE TOMA, VINCENZO TOMBOLINI and ENRICO CORTESI

Anticancer Research February 2022, 42 (2) 991-1000; DOI: https://doi.org/10.21873/anticanres.15559
You have access
Survival After Minimally Invasive Surgery in Older Women With Endometrial Carcinoma
JOEL CARDENAS-GOICOECHEA, YU WANG, JI-HYUN LEE, MASSOUD SHORAKA, SEMIRAMIS L. CARBAJAL-MAMANI, DAVID FISHMAN, ANDREA N. RINER and JOSE G. TREVINO

Anticancer Research January 2022, 42 (1) 75-85; DOI: https://doi.org/10.21873/anticanres.15459
You have access
The Benefit of Postoperative Radiotherapy and Extending Neck Dissection in pT1-2 Oral Squamous Cell Carcinoma With a Single Ipsilateral Cervical Lymph Node Metastasis (pN1)
UBAI ALSHARIF, DANIEL STELLER, MOHAMED FALOUGY, LARS THARUN, DIRK RADES and SAMER G. HAKIM

Anticancer Research January 2022, 42 (1) 97-104; DOI: https://doi.org/10.21873/anticanres.15462
You have access
Lung Cancer in Non-smokers in Czech Republic: Data from LUCAS Lung Cancer Clinical Registry
ONDREJ VENCLICEK, JANA SKRICKOVA, KRISTIAN BRAT, ONDREJ FISCHER, LIBOR HAVEL, MICHAL HRNCIARIK, MILOSLAV MAREL, PETR OPALKA, GABRIELA KRAKOROVA, DENISA ROZSIVALOVA, JURAJ KULTAN, ANDREA MULLEROVA, LYDIA ZARNAYOVA, PETRA SMICKOVA, MARTINA VASAKOVA, ZSUZSANNA GYORFY, MICHAL JIROUSEK, DANIEL KREJCI, JANA KREJCI, PETR ZUNA, MARTIN SVATON, KRISTYNA HRDA, JAROSLAV DUBA, JANA ALAHAKOON, MICHAL SVOBODA and JIRI SILAR

Anticancer Research November 2021, 41 (11) 5549-5556; DOI: https://doi.org/10.21873/anticanres.15368

Main menu

User menu

Search

survival

Pages